Summit Therapeutics Inc.
USD15.07
+0.21 (+1.41%)
CEO
Robert W. Duggan
IPO Date
2015-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.75
Prev. Close
$14.86
Day Low
$14.27
Day High
$15.11
52W Low
$13.83
52W High
$30.98
Market Cap
$11.68B
Volume
4.35M
| 11,232 |
| $17.52 |
| 6 Jan 2026 | DUGGAN ROBERT W | director, 10 percent owner, officer: Co-Chief Executive Officer | A-Award | Acquired | 11,232 | $17.52 |
| 6 Jan 2026 | Booth Robert F. | director | A-Award | Acquired | 35,000 | $17.52 |
| 6 Jan 2026 | Booth Robert F. | director | A-Award | Acquired | 7,180 | $17.52 |
| 6 Jan 2026 | Xia Yu | director | A-Award | Acquired | 35,000 | $17.52 |
| 6 Jan 2026 | Huber Jeff | director | A-Award | Acquired | 35,000 | $17.52 |
| 6 Jan 2026 | Huber Jeff | director | A-Award | Acquired | 9,885 | $17.52 |
| 6 Jan 2026 | Ronaghi Mostafa | director | A-Award | Acquired | 35,000 | $17.52 |
| 6 Jan 2026 | Clark Kenneth A | director | A-Award | Acquired | 35,000 | $17.52 |